← All companies
CLPT
ClearPoint Neuro, Inc.
$15.38
+0.80 +5.49%
Key statistics
from XBRL data in SEC filingsMarket cap
$469M
Revenue (TTM)
$42.3M
Net income (TTM)
-$34.6M
EPS (TTM)
$-1.17
P/E ratio
—
Dividend yield
—
Free cash flow
-$24.4M
Cash
$29.4M
Total assets
$86.7M
Gross margin
62.6%
52-week range
$8.27 – $30.10
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Aug 3, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 3, 2026
8-K
Director or officer change; Shareholder vote results
May 21, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 13, 2026
10-K
Fiscal year ended 2025-12-31
Mar 17, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 17, 2026
8-K/A
Feb 5, 2026
8-K
Results of operations (earnings release)
Jan 12, 2026
8-K
Entered a material agreement; Took on a direct financial obligation
Jan 5, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure
Nov 20, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 6, 2025
8-K
Entered a material agreement; Regulation FD disclosure
Nov 6, 2025
10-Q
Quarter ended 2025-06-30
Aug 12, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 12, 2025
8-K
Entered a material agreement
Jun 17, 2025
8-K
Director or officer change; Shareholder vote results
May 23, 2025
8-K
Other events
May 19, 2025
10-Q
Quarter ended 2025-03-31
May 13, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 13, 2025
8-K
Entered a material agreement; Other events
May 12, 2025
10-K
Fiscal year ended 2024-12-31
Feb 26, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 26, 2025
8-K
Entered a material agreement
Nov 7, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 7, 2024
8-K
Regulation FD disclosure
Aug 26, 2024
10-Q
Quarter ended 2024-06-30
Aug 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 7, 2024
8-K
Director or officer change; Shareholder vote results
May 16, 2024
10-Q
Quarter ended 2024-03-31
May 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
May 7, 2024
10-K
Fiscal year ended 2023-12-31
Mar 12, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Mar 12, 2024
8-K
Entered a material agreement
Mar 1, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 8, 2024
10-Q
Quarter ended 2023-09-30
Nov 9, 2023
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 9, 2023
10-Q
Quarter ended 2023-06-30
Aug 8, 2023